Daniel Mobilio
Hamilton, ON L8S4L8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.
Journal: Science translational medicine
Published: May 13, 2026
Emerging paradigms in the study of brain metastases.
Journal: Science signaling
Published: April 07, 2026
Depriving brain tumours of an amino acid could enhance chemotherapy.
Journal: Nature
Published: September 03, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.
Journal: Science translational medicine
Published: July 02, 2025
Isolation and Culture of Human Neural Stem Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 24, 2025
Efficient Migration Assay for Brain Tumor Stem Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 24, 2025
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.
Journal: Cell reports. Medicine
Published: December 11, 2023
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.
Journal: Nature medicine
Published: August 03, 2023
Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2023
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 13, 2023
Last Updated: 09/26/2026